Quantitative assessment of dyskinesias in subhuman primates.
Brotchie
J M
JM
Manchester Movement Disorder Laboratory, Division of Neuroscience, School of Biological Sciences, University of Manchester, UK.
Fox
S H
SH
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects; D003937:Diagnosis, Differential; D013759:Dronabinol / Q000031:analogs & derivatives / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D000882:Haplorhini; D019329:Idazoxan / Q000627:therapeutic use; D007980:Levodopa / Q000009:adverse effects; D011323:Primates; D012720:Severity of Illness Index
D000317:Adrenergic alpha-Antagonists; D014151:Anti-Anxiety Agents; D000978:Antiparkinson Agents; C011941:nabilone; D007980:Levodopa; D013759:Dronabinol; D019329:Idazoxan